Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Alley

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Bioorganic & Medicinal Chemistry|December 17, 2008
Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activityAhmed M Galal, Waseem Gul, Desmond Slade, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 10, 2004
Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cellsEileen Brantley, Valentina Trapani, Michael C Alley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2010
Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugateNicole M Okeley, Jamie B Miyamoto, Xinqun Zhang, et al.
Arthroplasty Today|June 17, 2026
Arthroscopic Treatment of Patellar Clunk Syndrome After Total Knee ArthroplastyMaxwell C Alley, W Doug Werry, Charles A Guerra, et al.
Cancer Research|October 27, 1997
2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenograftsD Marcantonio, L C Panasci, M G Hollingshead, et al.
Anticancer Research|July 1, 1992
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screenS F Stinson, M C Alley, W C Kopp, et al.
Nature Communications|December 9, 2020
A machine learning toolkit for genetic engineering attribution to facilitate biosecurityEthan C Alley, Miles Turpin, Andrew Bo Liu, et al.
Protein Engineering, Design & Selection : PEDS|April 29, 2006
Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachmentCharlotte F McDonagh, Eileen Turcott, Lori Westendorf, et al.
Cancer Research|September 18, 2004
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 2: efficacy evaluationsMichael C Alley, Melinda G Hollingshead, Christine M Pacula-Cox, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Molecular Cancer Therapeutics|February 20, 2007
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systemsMerrill E Goldsmith, Alian Aguila, Kenneth Steadman, et al.
Bioorganic & Medicinal Chemistry|December 17, 2008
Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activityAhmed M Galal, Waseem Gul, Desmond Slade, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 10, 2004
Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cellsEileen Brantley, Valentina Trapani, Michael C Alley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2010
Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugateNicole M Okeley, Jamie B Miyamoto, Xinqun Zhang, et al.
Arthroplasty Today|June 17, 2026
Arthroscopic Treatment of Patellar Clunk Syndrome After Total Knee ArthroplastyMaxwell C Alley, W Doug Werry, Charles A Guerra, et al.
Cancer Research|October 27, 1997
2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenograftsD Marcantonio, L C Panasci, M G Hollingshead, et al.
Anticancer Research|July 1, 1992
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screenS F Stinson, M C Alley, W C Kopp, et al.
Nature Communications|December 9, 2020
A machine learning toolkit for genetic engineering attribution to facilitate biosecurityEthan C Alley, Miles Turpin, Andrew Bo Liu, et al.
Protein Engineering, Design & Selection : PEDS|April 29, 2006
Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachmentCharlotte F McDonagh, Eileen Turcott, Lori Westendorf, et al.
Cancer Research|September 18, 2004
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 2: efficacy evaluationsMichael C Alley, Melinda G Hollingshead, Christine M Pacula-Cox, et al.
Pageof 14